Cancer Centre London
Private cancer day hospital in Wimbledon, London, part of Icon Group, delivering advanced radiotherapy, chemotherapy, immunotherapy, and targeted therapies to self-pay and insured patients across London and the South East.
- Company typePrivate
- Founded2003
- HeadquartersLondon, United Kingdom
- Headcount1–10
- GTM typeB2C
- OfferingServices
What Cancer Centre London does
Cancer Centre London, operating as Icon Cancer Centre UK, is a private oncology day hospital located at 49 Parkside, Wimbledon, London (SW19 5NB). Founded in 2003, the centre provides fee-for-service cancer treatment to private patients in London and surrounding areas, with payment made directly or through private health insurance. The facility is a UK subsidiary of Icon Group, the Asia-Pacific cancer care operator with centres across Australia, New Zealand, Singapore, Malaysia, Indonesia, and the UK, and operates in formal partnership with Nuffield Health to access its specialist network and patient referral pathways.
The centre's clinical offering centres on advanced radiation therapy, including stereotactic radiotherapy, HyperArc, adaptive radiotherapy, Deep Inspiration Breath Hold (DIBH), hydrogel spacer placement, external beam radiotherapy, and low-dose radiotherapy for benign conditions. This is complemented by systemic therapies — chemotherapy, immunotherapy, targeted therapies, hormone therapy, and theranostics — plus bone marrow collection and supportive services (counselling, pain management, palliative care, physiotherapy, dietetics). Patients are treated across breast, prostate, bowel, lung, and haematological cancers, blood disorders, and selected benign conditions, with a primary segment being breast cancer patients.
Go-to-market is hybrid: direct-to-consumer via website enquiry and phone, plus sales-led consultant and GP referrals through the Nuffield Health partnership. Pricing is quote-based per treatment course and not publicly disclosed. The centre is currently undertaking refurbishment works, indicating capital reinvestment in the existing facility. No revenue, headcount, or funding data are disclosed in the available sources.
Cancer Centre London firmographics
Firmographics- Name
- Cancer Centre London
- Legal name
- Icon Cancer Centre UK
- Website
- https://cancercentrelondon.co.uk
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Private cancer day hospital in Wimbledon, London, part of Icon Group, delivering advanced radiotherapy, chemotherapy, immunotherapy, and targeted therapies to self-pay and insured patients across London and the South East.
- Ownership category
- akta.pro rank
Cancer Centre London industry classification
Industry- Product category
- Oncology Services
- NAICS
- Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)
- SIC
- Services-Hospitals (8060)
- akta.pro primary industry
- Oncology & Cancer Specialty Hospitals (HLAFAHAC)
- akta.pro secondary industries
- Radiation Oncology (HLAKAFAC), Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)
Keywords
Where Cancer Centre London is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
Cancer Centre London business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Private Healthcare Services: Fee-for-service revenue model providing cancer treatment services including radiotherapy, chemotherapy, immunotherapy, and other treatments to private patients. As a private cancer centre, patients pay for treatment directly or through private health insurance.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Quote-based pricing for individual treatment courses |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
Cancer Centre London product offering
Product offeringCore offering
Cancer Centre London (operating as Icon Cancer Centre UK) is a private cancer treatment hospital in Wimbledon providing comprehensive oncology services to patients across London and surrounding areas. The centre delivers advanced radiotherapy (including stereotactic, HyperArc, adaptive, DIBH, hydrogel, EBRT, and low-dose techniques), chemotherapy, immunotherapy, hormone therapy, targeted therapies, theranostics, and bone marrow collection. Services are organised around specific cancer types including breast, prostate, bowel, lung, blood cancers, blood disorders, and selected benign conditions.
Product overview
Icon Cancer Centre London operates as a private healthcare facility offering integrated cancer treatment services. The centre provides a comprehensive portfolio of treatment modalities including radiotherapy (with advanced techniques such as HyperArc, Adaptive radiotherapy, and Stereotactic radiotherapy), chemotherapy, immunotherapy, hormone therapy, targeted therapies, theranostics, and bone marrow collection. The centre specializes in treating various cancer types including breast, prostate, bowel, lung, and blood cancers, as well as blood disorders and benign conditions. Patient support services including a cancer library, support services for families and carers, and care coordination complement the clinical treatments. The centre operates in partnership with Nuffield Health to deliver coordinated cancer care.
Differentiator
Problem solved
Functional benefit
Products and services
- Radiotherapy Cancer treatment using targeted radiation, delivered through advanced techniques including stereotactic radiotherapy, HyperArc, adaptive radiotherapy, Deep Inspiration Breath Hold (DIBH), hydrogel spacers, external beam radiotherapy (EBRT), and low-dose radiotherapy (LDRT). Provided to patients seeking precision radiation treatment at the Wimbledon centre.
- Chemotherapy Systemic cancer treatment using cytotoxic drugs to destroy cancer cells, offered with supporting services for starting treatment and managing side effects.
- Immunotherapy Cancer treatment that harnesses the body's immune system to fight cancer cells, including checkpoint inhibitors and other immune-modulating therapies.
- Hormone Therapy Cancer treatment using hormones to slow or stop the growth of certain cancers.
- Targeted Therapies Precision cancer treatments that target specific genes, proteins, or pathways unique to a patient's cancer to block tumour growth and spread.
- Theranostics Combined diagnostic and therapeutic approach using radiopharmaceuticals to both identify and treat cancer cells simultaneously.
- Bone Marrow Collection Procedure for collecting bone marrow stem cells for transplantation or therapeutic purposes.
- Icon Cancer Centre London (Wimbledon facility) Private cancer treatment centre located at 49 Parkside, Wimbledon, London SW19 5NB, providing comprehensive cancer care including radiotherapy, chemotherapy, immunotherapy, hormone therapy, targeted therapies, theranostics, and bone marrow collection for patients across London and surrounding areas.
- Breast Cancer Treatment Specialised diagnosis and treatment services for breast cancer patients, including radiotherapy, chemotherapy, hormone therapy, and targeted therapies with techniques such as Deep Inspiration Breath Hold to minimise cardiac exposure.
- Prostate Cancer Treatment Specialised diagnosis and treatment services for prostate cancer patients, including radiotherapy with hydrogel spacer technique to reduce rectal side effects, hormone therapy, and targeted approaches.
- Bowel Cancer Treatment Specialised diagnosis and treatment services for bowel (colorectal) cancer patients, including radiotherapy and systemic therapies with coordinated multidisciplinary care.
- Lung Cancer Treatment Specialised diagnosis and treatment services for lung cancer patients, including radiotherapy, chemotherapy, immunotherapy, and targeted therapies.
- Blood Cancers Treatment Treatment services for haematological malignancies including leukaemia, lymphoma, and myeloma, with systemic therapies and bone marrow collection.
- Blood Disorders Treatment Treatment services for non-malignant blood disorders including anaemia, iron deficiency, haemochromatosis, and myelodysplasia.
- Benign Conditions Treatment Low-dose radiotherapy treatment for benign conditions including Dupuytren's disease, Ledderhose disease, osteoarthritis, and plantar fasciitis.
Companies that use Cancer Centre London
Customer profileSegments6 records
Ideal customer profiles2 records
Cancer Centre London technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature12 records
Cancer Centre London partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Nuffield HealthcoreIcon Cancer Centre has a partnership with Nuffield Health to deliver seamless, high-quality cancer care. Patients benefit from access to world-class treatments, care from leading consultants, and coordinated support from hundreds of specialists. The partnership enables integrated care pathways combining Nuffield Health's facilities and specialist network with Icon's cancer expertise.
Scale indicators1 record
Recent moves5 records
Expansion highlights5 records
Cancer Centre London competitors and assessment
Company assessmentOthers
- Nuffield Health: Strategic partner of Cancer Centre London. Operates a UK network of private hospitals and fitness/wellness facilities and refers cancer patients to Icon's London centre — comparable as a private-pay UK healthcare ecosystem participant and partner-channel.
- Bupa Health Services: Major UK private health insurer and provider with cancer treatment pathways. Comparable as a counterparty in the UK private cancer care ecosystem — both a potential payer (reimbursing Cancer Centre London treatments) and an indirect competitor via its own health services.
Broad incumbents
- Spire Healthcare: UK-wide private hospital group offering oncology services including chemotherapy across multiple London and regional sites. Comparable on the private-pay oncology delivery model, though less specialist depth than a dedicated cancer centre.
- The London Clinic: Large independent private hospital in central London offering oncology among many other specialties. Comparable as a London private-pay provider with cancer services, but broader scope and less specialist depth in advanced radiotherapy.
- London Bridge Hospital (HCA Healthcare UK): Flagship HCA private hospital in London with a significant cancer services programme. Overlaps with Cancer Centre London in private oncology delivery but sits within a much larger multi-specialty private hospital group.
- Cromwell Hospital: London private hospital offering cancer diagnostics and treatment services including radiotherapy. Comparable as a private London provider, though broader multi-specialty positioning rather than a dedicated oncology centre.
- Ramsay Health Care UK: International private hospital operator with UK sites offering cancer treatment including chemotherapy and radiotherapy. Comparable as a private-pay provider but operates a broad multi-specialty portfolio rather than a focused cancer offering.
Direct peers
- The Royal Marsden Private Care: The UK's most renowned specialist cancer hospital, offering private patient services in London with comprehensive radiotherapy, chemotherapy and systemic therapy — directly comparable to Cancer Centre London in service mix, technology depth and London private-pay patient base.
- GenesisCare UK: Specialist private cancer care provider with multiple UK centres offering advanced radiotherapy (including stereotactic), chemotherapy and theranostics — directly comparable technology stack and private-pay model with a multi-site UK footprint that Icon Cancer Centre London lacks.
- Leaders in Oncology Care (LOC): London-based private oncology provider (part of HCA Healthcare UK) delivering chemotherapy, immunotherapy, radiotherapy and supportive care — competes head-on with Cancer Centre London for self-pay and insured cancer patients in central London.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Cancer Centre London social profiles
Digital presenceCancer Centre London financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cancer Centre London leadership team
Management profileNumber of profiles
Cancer Centre London funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cancer Centre London M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cancer Centre London
What does Cancer Centre London do?
Cancer Centre London (operating as Icon Cancer Centre UK) is a private cancer treatment hospital in Wimbledon providing comprehensive oncology services to patients across London and surrounding areas. The centre delivers advanced radiotherapy (including stereotactic, HyperArc, adaptive, DIBH, hydrogel, EBRT, and low-dose techniques), chemotherapy, immunotherapy, hormone therapy, targeted therapies, theranostics, and bone marrow collection. Services are organised around specific cancer types including breast, prostate, bowel, lung, blood cancers, blood disorders, and selected benign conditions.
Is Cancer Centre London a public or private company?
Cancer Centre London is a private company. It is classified as corporate owned and is currently operating.
When was Cancer Centre London founded?
Cancer Centre London was founded in 2003. It employs 1 to 10 people.
Where is Cancer Centre London based?
Cancer Centre London is headquartered in London, United Kingdom, in the Europe region.
How does Cancer Centre London make money?
One revenue line is on record: private Healthcare Services.
Who are Cancer Centre London's main competitors?
Others on record are Nuffield Health and Bupa Health Services. Broad incumbents are Spire Healthcare, The London Clinic, London Bridge Hospital (HCA Healthcare UK), Cromwell Hospital and Ramsay Health Care UK. Direct peers are The Royal Marsden Private Care, GenesisCare UK and Leaders in Oncology Care (LOC).
Does Cancer Centre London have an API?
No public API is recorded for Cancer Centre London.
What industry is Cancer Centre London in?
Cancer Centre London's product category is Oncology Services. Its primary akta.pro industry code is HLAFAHAC, Oncology & Cancer Specialty Hospitals, with a secondary code of HLAKAFAC, Radiation Oncology. Its NAICS code is 622310 and its SIC code is 8060.